期刊
ACS MATERIALS LETTERS
卷 3, 期 9, 页码 1284-1290出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmaterialslett.1c00329
关键词
-
资金
- Singapore National Research Foundation [R279-000-483-281]
- NUS [R279-000-482-133]
- Science and Technology Key Project of Shenzhen [JCYJ20200109114612308, JCYJ20190812163614809]
- National Natural Science Foundation of China [91859117, 81771906, 81971638]
- Shenzhen Key Laboratory of Ultrasound Imaging and Therapy [ZDSYS201802061806314]
- CAS Key Laboratory of Health Informatics [2011DP173015]
- Shenzhen Double Chain Grant [[2018]256]
The study developed a lipid-decorated molecular photoacoustic contrast agent TFML, which effectively labeled live neutrophils for targeted brain tumor imaging in mice glioblastoma multiforme detection. This approach presents a promising prospect for neutrophil-based nanotherapeutics research.
The delivery of imaging agents to brain tumor sites has been a longstanding hindrance, because of the presence of blood-brain barriers (BBB) and the complex brain tumor microenvironment. The living cell-based delivery system has shown tantalizing prospects for therapeutic applications targeting oncological diseases. Herein, we design a lipid- decorated molecular photoacoustic contrast agent TFML, which can effectively label harvested live neutrophils without affecting the activation and transmigration functions. After labeling neutrophils with TFML probes, TFML-labeled neutrophil (TFML-NE) was adoptively transferred into the recipient body and demonstrated strong PA signals, good brain tumor-targeting capability, and was applied for mice glioblastoma multiforme (GBM) detection. The successful development of TFML probes for neutrophil labeling and brain tumor targeting PAI presents a promising prospect for neutrophil-based nanotherapeutics studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据